Mass Balance Study of [14C]Chiauranib

Clinical trial NCT05371899 · COMPLETED

Trial details

NCT number: NCT05371899
Sponsor: Chipscreen Biosciences, Ltd.
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Small Cell Lung Cancer

Start date: 2022-07-20
Primary completion: 2024-03-18
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.